Nuveen Asset Management LLC Cuts Stock Holdings in Anthem, Inc. (NYSE:ANTM)

Nuveen Asset Management LLC reduced its holdings in Anthem, Inc. (NYSE:ANTMGet Rating) by 5.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,348,630 shares of the company’s stock after selling 132,059 shares during the period. Nuveen Asset Management LLC’s holdings in Anthem were worth $1,088,683,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also modified their holdings of ANTM. Industrial Alliance Investment Management Inc. purchased a new position in shares of Anthem during the 4th quarter worth about $26,000. Trust Co. of Vermont bought a new stake in Anthem during the 4th quarter valued at about $31,000. Bell Investment Advisors Inc bought a new stake in shares of Anthem in the 3rd quarter valued at about $37,000. Fieldpoint Private Securities LLC raised its holdings in shares of Anthem by 57.8% in the 3rd quarter. Fieldpoint Private Securities LLC now owns 101 shares of the company’s stock valued at $38,000 after purchasing an additional 37 shares in the last quarter. Finally, Benjamin Edwards Inc. raised its holdings in shares of Anthem by 145.9% in the 4th quarter. Benjamin Edwards Inc. now owns 91 shares of the company’s stock valued at $42,000 after purchasing an additional 54 shares in the last quarter. 84.28% of the stock is owned by institutional investors and hedge funds.

NYSE ANTM traded up $7.65 during trading on Thursday, reaching $512.43. 987,931 shares of the company’s stock were exchanged, compared to its average volume of 1,193,833. The stock has a market cap of $123.54 billion, a P/E ratio of 20.17, a price-to-earnings-growth ratio of 1.35 and a beta of 0.97. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.36 and a current ratio of 1.36. The company has a 50 day moving average price of $498.07 and a two-hundred day moving average price of $462.51. Anthem, Inc. has a 1 year low of $355.43 and a 1 year high of $533.68.

Anthem (NYSE:ANTMGet Rating) last announced its quarterly earnings results on Wednesday, April 20th. The company reported $8.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.81 by $0.44. The company had revenue of $38.10 billion during the quarter, compared to the consensus estimate of $37.28 billion. Anthem had a return on equity of 18.71% and a net margin of 4.33%. Anthem’s revenue for the quarter was up 17.6% on a year-over-year basis. During the same period in the previous year, the business earned $7.01 EPS. Research analysts forecast that Anthem, Inc. will post 28.55 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, June 24th. Stockholders of record on Friday, June 10th will be issued a $1.28 dividend. This is an increase from Anthem’s previous quarterly dividend of $1.13. This represents a $5.12 annualized dividend and a dividend yield of 1.00%. The ex-dividend date is Thursday, June 9th. Anthem’s payout ratio is presently 20.16%.

In other Anthem news, Director Ramiro G. Peru sold 990 shares of the company’s stock in a transaction that occurred on Thursday, May 19th. The stock was sold at an average price of $468.88, for a total transaction of $464,191.20. Following the completion of the sale, the director now directly owns 9,405 shares of the company’s stock, valued at approximately $4,409,816.40. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Ronald W. Penczek sold 2,423 shares of the company’s stock in a transaction that occurred on Thursday, March 3rd. The shares were sold at an average price of $463.68, for a total value of $1,123,496.64. The disclosure for this sale can be found here. Insiders sold a total of 21,116 shares of company stock valued at $9,743,637 over the last three months. Company insiders own 0.28% of the company’s stock.

A number of research analysts have recently issued reports on the stock. SVB Leerink lifted their price objective on shares of Anthem from $483.00 to $555.00 and gave the stock a “market perform” rating in a research report on Thursday, April 21st. The Goldman Sachs Group boosted their target price on shares of Anthem from $527.00 to $605.00 and gave the stock a “buy” rating in a research report on Thursday, April 21st. Argus boosted their target price on shares of Anthem from $475.00 to $500.00 and gave the stock a “buy” rating in a research report on Monday, February 7th. UBS Group boosted their target price on shares of Anthem from $477.00 to $541.00 and gave the stock a “buy” rating in a research report on Tuesday, March 29th. Finally, Cowen boosted their target price on shares of Anthem from $472.00 to $642.00 in a research report on Thursday, April 21st. Two investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $544.95.

Anthem Company Profile (Get Rating)

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.

Read More

Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem, Inc. (NYSE:ANTMGet Rating).

Institutional Ownership by Quarter for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.